David Malcom Rodman, Chief Medical Officer at Mineralys Therapeutics, Inc. (MLYS), sold 525,504 shares at $35.87 ($18.5M) on 2026-01-02, disclosed to the SEC on 2026-01-06.
Open-market sale of $18.5M MLYS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.87 | 70,037 | $2.5M | 13.6% |
| 2 | $35.87 | 70,037 | $2.5M | 13.6% |
| 3 | $34.83 | 139,245 | $4.8M | 26.2% |
| 4 | $34.83 | 139,245 | $4.8M | 26.2% |
| 5 | $35.53 | 53,470 | $1.9M | 10.3% |
| 6 | $35.53 | 53,470 |
| $1.9M |
| 10.3% |
| Total | $35.25 avg | 525,504 | $18.5M | 100% |
| Filing → |
| MLYS | SELL | 2026-07-15 | $557K | — | Filing → |
| MLYS | SELL | 2026-07-10 | $66K | — | Filing → |
| MLYS | SELL | 2026-06-17 | $350K | — | Filing → |